Pancreatic beta cell function enhancement

The concept of "pancreatic beta cell function enhancement" refers to therapies or interventions that improve the insulin-secreting capacity or survival of pancreatic beta cells, primarily for treatment of diabetes mellitus. This includes a wide array of molecular targets such as receptors, enzymes, channels, and growth factors. Enhancement generally involves stimulating insulin secretion in response to glucose, promoting beta cell mass via proliferation or neogenesis, preventing apoptosis, and protecting cells against metabolic, oxidative, and inflammatory stress. This concept encompasses multiple drug classes, targets, and physiological mechanisms rather than a single molecular entity.

Enhancing insulin secretion (e.g., via GLP-1 receptor activation); Stimulating beta cell proliferation (e.g., via hepatocyte growth factor, paired box gene 4); Reducing beta cell apoptosis (e.g., inhibiting NF-κB pathway; anti-apoptotic gene expression); Protecting against oxidative and ER stress.